Pathstone Holdings »

Amicus Therapeutics shares owned by Pathstone Holdings

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Pathstone Holdings from 13F filings

Historical chart of Pathstone Holdings investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Pathstone Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Pathstone Holdings

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.2M 106k 11.78
2023-12-31 $1.5M 105k 14.19

More positions owned by Pathstone Holdings

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Crowdstrike Hldgs Cl A (CRWD)
NVIDIA Corporation (NVDA)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Amazon (AMZN)
Vanguard Index Fds Large Cap Etf (VV)

View all positions for Pathstone Holdings

Top funds holding Amicus Therapeutics

Vanguard Group
Perceptive Advisors
venBio Select Advisor
BlackRock
Jpmorgan Chase & Co
Wellington Management Company
Henderson Group
Redmile Group
William Blair Investment Management
Morgan Stanley
Palo Alto Investors
Pictet Asset Management Holding SA
Geode Capital Management
Fiera Capital Corporation
American Century Companies

View all funds holding Amicus Therapeutics